Skip to main content
PLOS One logoLink to PLOS One
. 2016 May 24;11(5):e0156471. doi: 10.1371/journal.pone.0156471

Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial

Anete Trajman, Betina Durovni, Valeria Saraceni, Alexandre Menezes, Marcelo Cordeiro-Santos, Frank Cobelens, Susan Van den Hof
PMCID: PMC4878764  PMID: 27219325

There are a number of errors in the “aOR (95%CI)” columns for Tables 3 and 4. During secondary analysis, the authors observed 128 duplicate entries in the study database among 4054 included in the analyses. Despite observing the random distribution of duplicates, the authors performed all analyses again after removal of the 128 duplicates (leaving 3926 patients in the analyses) and found negligible effect on the outcome measures: aOR for arm associated with unfavourable outcome now 0.93 (0.80–1.09) compared to 0.93 (0.79–1.08) in the original article; while aOR for TB-attributed deaths is 0.69 (0.46–1.04) compared to 0.65 (0.44–0.97). Even though the 95% confidence interval of the aOR for TB attributed death now includes 1, the difference with the originally reported aOR and the width of its confidence interval are minimal, hence the conclusions from the results remain unchanged. Please see the correct Tables 3 and 4 here.

Table 3. Characteristics associated with unfavourable outcomes in a multilevel logistic regression model.

Characteristics Unfavourable (n = 1181) Successful (n = 2745) crude OR (95%CI) aOR (95%CI)
Sex
Male 846 (33.2%) 1700 (66.8%) 1.5 (1.3–1.8) 1.5 (1.3–1.8)
Female 335 (24.3%) 1045 (75.7%) 1 (reference) 1 (reference)
Age group (years)
0–14 18 (19.8%) 73 (80.2%) 0.76 (0.44–1.32) 0.69 (0.39–1.3)
15–29 704 (33.8%) 1378 (66.2%) 1.6 (1.3–2.0) 1.6 (1.2–2.0)
30–59 347 (26.9%) 943 (73.1%) 1.1 (0.90–1.5) 1.1 (0.86–1.4)
≥60 112 (24.2%) 351 (75.8%) 1 (reference) 1 (reference)
HIV status
Negative 452 (21.2%) 1675 (78.8%) 1 (reference) 1 (reference)
Positive 171 (43.7%) 220 (56.3%) 2.9 (2.3–3.7) 3.1 (2.4–3.9)
Unknown 558 (39.6%) 850 (60.4%) 2.6 (2.2–3.0) 2.6 (2.2–3.0)
City
Manaus 222 (28.5%) 556 (71.5%) 1 (reference) 1 (reference)
Rio 959 (30.5%) 2189 (69.5%) 1.1 (0.81–1.4) 1.3 (1.01–1.7)
Type of diagnosis
Confirmed* 875 (30.9%) 1960 (69.1%) 1 (reference) 1 (reference)
Clinically diagnosed, negative test§ 198 (28.5%) 496 (71.5%) 0.89 (0.73–1.1) 0.86 (0.71–1.04)
Clinically diagnosed, no test result 108 (27.2%) 289 (72.8%) 0.82 (0.65–1.04) 0.76 (0.59–0.97)
Arm
Baseline 556 (31.3%) 1221 (68.7%) 1 (reference) 1 (reference)
Intervention 625 (29.1%) 1524 (70.9%) 0.92 (0.79–1.06) 0.93 (0.80–1.09)

*Positive smear in baseline arm and positive Xpert in intervention arm.

§Negative smear in baseline arm and negative Xpert in intervention arm.

†Unfavourable = loss to follow up, death from any cause, transfer out and resistance.

Table 4. Characteristics associated with TB-attributed death in a multilevel logistic regression model.

Characteristics TB-attributed death (n = 119) Successful (n = 2745) crude OR (95%CI) aOR (95%CI)
Sex
Male 83 (4.7%) 1700 (95.3%) 1.4 (0.95–2.1) -
Female 36 (3.3%) 1045 (96.7%) 1.0 (reference)
Age group (years)
0–14 1 (1.3%) 73 (98.7%) 0.20 (0.03–1.6) 0.14 (0.02–1.01)
15–29 49 (3.4%) 1378 (96.6%) 0.54 (0.33–0.9) 0.44 (0.26–0.76)
30–59 46 (4.6%) 943 (95.4%) 0.74 (0.44–1.2) 0.57 (0.33–0.98)
≥60 23 (6.1%) 351 (93.9%) 1.0 (reference) 1.0 (reference)
HIV status
Negative 25 (1.5%) 1675 (98.5%) 1.0 (reference) 1.0 (reference)
Positive 44 (16.7%) 220 (83.3%) 14.0 (8.1–24.2) 16.1 (9.2–28.3)
Unknown 50 (5.6%) 850 (94.4%) 4.1 (2.4–6.7) 4.3 (2.6–7.1)
City
Manaus 21 (3.6%) 556 (96.4%) 1.2 (0.73–1.9) 1.96 (1.01–3.8)
Rio 98 (4.3%) 2189 (95.7%) 1.0 (reference) 1.0 (reference)
Type of diagnosis
Confirmed* 81 (4.0%) 1960 (96.0%) 1.0 (reference)
Clinically diagnosed, negative test§ 25 (4.8%) 496 (95.2%) 1.2 (0.77–1.9) -
Clinically diagnosed, no test result 13 (4.3%) 289 (95.7%) 1.1 (0.59–2.0)
Arm
Baseline 68 (5.3%) 1221 (94.7%) 1.0 (reference) 1.0 (reference)
Intervention 51 (3.2%) 1524 (96.8%) 0.60 (0.42–0.85) 0.69 (0.46–1.04)

OR = odds ratio, aOR = adjusted odds ratio

*Positive smear in baseline arm and positive Xpert in intervention arm

§ Negative smear in baseline arm and negative Xpert in intervention arm

Reference

  • 1.Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, et al. (2015) Impact on Patients’ Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. PLoS ONE 10(4): e0123252 doi:10.1371/journal.pone.0123252 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES